Tuberculosis News and Research

Latest Tuberculosis News and Research

'Big Push' needed to ensure political will necessary to maintain progress against AIDS, TB, malaria

"What will the day be like when we finally defeat AIDS, tuberculosis and malaria?" Arianna Huffington, president and editor-in-chief of the Huffington Post Media Group, asks in the Huffington Post's "The Big Push" blog.

26 Sep 2012

IVAC at Johns Hopkins announces grant recipients of World Pneumonia Day Advocacy Program

The International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health (JHSPH) announced today recipients of the 2012 Small Grants for World Pneumonia Day Advocacy Program.

25 Sep 2012

U.S. foreign aid critical to achieving health goals, improving lives, strengthening international relationships

"Day after day, American foreign aid is dramatically improving millions of lives and consequently, impressions of America," former New Jersey Governor Thomas Kean and Ray Chambers, chair of the MDG Health Alliance and the U.N. Secretary-General's Special Envoy for Malaria, write in the Huffington Post's "Global Motherhood" blog.

21 Sep 2012

Sanofi, TB Alliance form research collaboration to search for new treatment compounds

French drug maker Sanofi on Thursday announced a new three-year research collaboration agreement with the TB Alliance "to accelerate the discovery and development of novel compounds against tuberculosis," RTTNews reports.

21 Sep 2012

U.N. report on MDGs shows declining aid; SG Ban urges increased global partnership

U.N. Secretary-General Ban Ki-moon on Thursday "urged a stronger global partnership to advance progress on the development targets world leaders have pledged to achieve by 2015, as a new United Nations report finds that significant gains risk slowing due to declining aid," the U.N. News Centre reports.

21 Sep 2012

September issue of 'Global Fund News Flash' email newsletter available

The Global Fund to Fight AIDS, Tuberculosis and Malaria has published Issue 8 of its newsletter, the "Global Fund News Flash."

21 Sep 2012

MD Anderson introduces Moon Shots Program to reduce cancer deaths

The University of Texas MD Anderson Cancer Center announces the launch of the Moon Shots Program, an unprecedented effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths.

21 Sep 2012

First phase of Global Fund-managed AMFm shows success in bringing malaria drugs to clinics

The Affordable Medicines Facility-malaria (AMFm) -- an innovative financing mechanism that subsidizes the cost of artemisinin-based combination therapies (ACTs) in order to expand access to the most effective treatment for malaria -- "brought more than 100 million doses of malaria drugs to clinics and pharmacies in 2011" and "also increased access to the top malaria medicines by 26 to 52 percent in six countries."

21 Sep 2012

TB Alliance, Sanofi partner to discover and develop novel compounds against tuberculosis

Sanofi and the Global Alliance for TB Drug Development announced today a new research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis (TB), a deadly infectious disease that resulted in almost 1.5 million deaths worldwide in 2010.

21 Sep 2012

Global health funding cuts threatening fight against HIV, TB in Eastern Europe, Central Asia, NGO report says

The fight against HIV and tuberculosis (TB) in Eastern Europe and Central Asia is being threatened by cuts in global health funding, according to "a report [.pdf] by leading European non-governmental health organizations," Reuters reports.

20 Sep 2012

Improved health critical to development of democracy in Burma

In this post in the Huffington Post Blog, Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, examines the role of health efforts in the rebuilding of Burma, also known as Myanmar.

19 Sep 2012

Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting

Pfizer Inc. announced today that 14 abstracts for tofacitinib, an investigational oral Janus kinase (JAK) inhibitor for the treatment of adults with moderate-to-severe active rheumatoid arthritis (RA), will be presented at the American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) 2012 Annual Meeting, which is being held November 9-14 in Washington, D.C.

18 Sep 2012

Global Fund Board adopts new approach to funding grants

According to a press release from the Global Fund to Fight AIDS, Tuberculosis and Malaria, the fund's Board on Friday "voted to adopt a new approach to funding grants that will enable the organization to invest the world's money more strategically and for greater impact."

17 Sep 2012

Natural antibiotic to treat tuberculosis

A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO Molecular Medicine. A team of scientists working in Switzerland has shown how pyridomycin, a natural antibiotic produced by the bacterium Dactylosporangium fulvum, works.

17 Sep 2012

Drug-resistant tuberculosis: an interview with Sven Hoffner

In contrast to drug-susceptible tuberculosis, which can be cured with available drug therapies, drug-resistant, and especially multi-drug resistant, tuberculosis is much more difficult to cure and it takes a much longer time for patients to become non-infectious.

17 Sep 2012

Global Fund board members discuss new funding allocation model amid some concerns from TB advocates

The board of the Global Fund to Fight AIDS, Tuberculosis and Malaria began a two-day meeting in Geneva on Thursday, "with one topic high on the agenda: a new funding model," Devex's "Development Newswire" reports.

15 Sep 2012

Wits’ Health Sciences Research Day and Postgraduate Expo to take place on Sep. 19

The 2012 Health Sciences Research Day and Postgraduate Expo takes place on Wednesday, 19 September 2012 under the theme: Excellence. Relevance. Determination. Transforming Life through Research Excellence.

14 Sep 2012

Lilly, Boehringer Ingelheim announce availability of My Well Planner for adults with type 2 diabetes

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announce the availability of a new online program offering customized educational content to help adults with type 2 diabetes make simple lifestyle changes to improve their health.

14 Sep 2012

Examining effects of reduced AIDS funding for Ethiopia

Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development (CGD), and Kate McQueston, a program coordinator at CGD, write in the center's "Global Health Policy" blog that a reduction in AIDS funding to Ethiopia from PEPFAR and the Global Fund to Fight AIDS, Tuberculosis and Malaria "might be warranted due to epidemiological trends and improved efficiency, or might cripple progress as health programs dependent on external donors are cut back."

13 Sep 2012

Old anti-inflammatory drug possible candidate to treat TB

After testing about 5,600 existing medications for their effectiveness against drug-resistant strains of tuberculosis (TB), researchers from Weill Cornell Medical College reported this week in the Proceedings of the National Academy of Sciences that oxyphenbutazone, "an anti-inflammatory medication marketed in the 1950s as Tandearil and still used in veterinary medicine," killed both latent and active TB bacteria in test-tube experiments, the Los Angeles Times' "Booster Shots" blog reports.

13 Sep 2012

Tuberculosis News and Research

Latest Tuberculosis News and Research

'Big Push' needed to ensure political will necessary to maintain progress against AIDS, TB, malaria

IVAC at Johns Hopkins announces grant recipients of World Pneumonia Day Advocacy Program

U.S. foreign aid critical to achieving health goals, improving lives, strengthening international relationships

Sanofi, TB Alliance form research collaboration to search for new treatment compounds

U.N. report on MDGs shows declining aid; SG Ban urges increased global partnership

September issue of 'Global Fund News Flash' email newsletter available

MD Anderson introduces Moon Shots Program to reduce cancer deaths

First phase of Global Fund-managed AMFm shows success in bringing malaria drugs to clinics

TB Alliance, Sanofi partner to discover and develop novel compounds against tuberculosis

Global health funding cuts threatening fight against HIV, TB in Eastern Europe, Central Asia, NGO report says

Improved health critical to development of democracy in Burma

Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting

Global Fund Board adopts new approach to funding grants

Natural antibiotic to treat tuberculosis

Drug-resistant tuberculosis: an interview with Sven Hoffner

Global Fund board members discuss new funding allocation model amid some concerns from TB advocates

Wits’ Health Sciences Research Day and Postgraduate Expo to take place on Sep. 19

Lilly, Boehringer Ingelheim announce availability of My Well Planner for adults with type 2 diabetes

Examining effects of reduced AIDS funding for Ethiopia

Old anti-inflammatory drug possible candidate to treat TB

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Tuberculosis News and Research

Latest Tuberculosis News and Research

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Newsletters you may be interested in